BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 27077458)

  • 1. The Effect of n-3 Polyunsaturated Fatty Acid Supplementation on Androgen Status in Patients with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis of Clinical Trials.
    Hajishafiee M; Askari G; Iranj B; Ghiasvand R; Bellissimo N; Totosy de Zepetnek J; Salehi-Abargouei A
    Horm Metab Res; 2016 May; 48(5):281-9. PubMed ID: 27077458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Effect of Vitamin D Supplementation on the Androgenic Profile in Patients with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis of Clinical Trials.
    Azadi-Yazdi M; Nadjarzadeh A; Khosravi-Boroujeni H; Salehi-Abargouei A
    Horm Metab Res; 2017 Mar; 49(3):174-179. PubMed ID: 28351084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of atorvastatin on testosterone levels.
    Shawish MI; Bagheri B; Musini VM; Adams SP; Wright JM
    Cochrane Database Syst Rev; 2021 Jan; 1(1):CD013211. PubMed ID: 33482034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of omega-3 polyunsaturated fatty acids on hormones, oxidative stress, and inflammatory parameters among polycystic ovary syndrome: a systematic review and meta-analysis.
    Yuan J; Wen X; Jia M
    Ann Palliat Med; 2021 Aug; 10(8):8991-9001. PubMed ID: 34488386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hormonal and metabolic effects of polyunsaturated fatty acids in young women with polycystic ovary syndrome: results from a cross-sectional analysis and a randomized, placebo-controlled, crossover trial.
    Phelan N; O'Connor A; Kyaw Tun T; Correia N; Boran G; Roche HM; Gibney J
    Am J Clin Nutr; 2011 Mar; 93(3):652-62. PubMed ID: 21270384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of probiotics, prebiotics, and synbiotics on hormonal and inflammatory indices in women with polycystic ovary syndrome: a systematic review and meta-analysis.
    Shamasbi SG; Ghanbari-Homayi S; Mirghafourvand M
    Eur J Nutr; 2020 Mar; 59(2):433-450. PubMed ID: 31256251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atorvastatin therapy decreases androstenedione and dehydroepiandrosterone sulphate concentrations in patients with polycystic ovary syndrome: randomized controlled study.
    Sathyapalan T; Smith KA; Coady AM; Kilpatrick ES; Atkin SL
    Ann Clin Biochem; 2012 Jan; 49(Pt 1):80-5. PubMed ID: 21972424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of omega-3 fatty acids supplementation on insulin resistance in women with polycystic ovary syndrome: Meta-analysis of randomized controlled trials.
    Sadeghi A; Djafarian K; Mohammadi H; Shab-Bidar S
    Diabetes Metab Syndr; 2017; 11(2):157-162. PubMed ID: 27484441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of vitamin D supplementation in combination with low-calorie diet on anthropometric indices and androgen hormones in women with polycystic ovary syndrome: a double-blind, randomized, placebo-controlled trial.
    Jafari-Sfidvajani S; Ahangari R; Hozoori M; Mozaffari-Khosravi H; Fallahzadeh H; Nadjarzadeh A
    J Endocrinol Invest; 2018 May; 41(5):597-607. PubMed ID: 29110281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of pharmacological interventions on biochemical hyperandrogenemia in women with polycystic ovary syndrome: a systematic review and meta-analysis of randomised controlled trials.
    Abdalla MA; Shah N; Deshmukh H; Sahebkar A; Östlundh L; Al-Rifai RH; Atkin SL; Sathyapalan T
    Arch Gynecol Obstet; 2023 May; 307(5):1347-1376. PubMed ID: 35434762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chromium supplementation and polycystic ovary syndrome: A systematic review and meta-analysis.
    Fazelian S; Rouhani MH; Bank SS; Amani R
    J Trace Elem Med Biol; 2017 Jul; 42():92-96. PubMed ID: 28595797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Comparison of the Hormonal Profile of Early Androgenetic Alopecia in Men With the Phenotypic Equivalent of Polycystic Ovarian Syndrome in Women.
    Sanke S; Chander R; Jain A; Garg T; Yadav P
    JAMA Dermatol; 2016 Sep; 152(9):986-91. PubMed ID: 27304785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ovulation after glucocorticoid suppression of adrenal androgens in the polycystic ovary syndrome is not predicted by the basal dehydroepiandrosterone sulfate level.
    Azziz R; Black VY; Knochenhauer ES; Hines GA; Boots LR
    J Clin Endocrinol Metab; 1999 Mar; 84(3):946-50. PubMed ID: 10084576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of metformin on endogenous androgens and SHBG in women: a systematic review and meta-analysis.
    Barba M; Schünemann HJ; Sperati F; Akl EA; Musicco F; Guyatt G; Muti P
    Clin Endocrinol (Oxf); 2009 May; 70(5):661-70. PubMed ID: 19178532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of selenium supplementation on glucose homeostasis and free androgen index in women with polycystic ovary syndrome: A randomized, double blinded, placebo controlled clinical trial.
    Mohammad Hosseinzadeh F; Hosseinzadeh-Attar MJ; Yekaninejad MS; Rashidi B
    J Trace Elem Med Biol; 2016 Mar; 34():56-61. PubMed ID: 26854246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Two Different Doses of Vitamin D Supplementation on Metabolic Profiles of Insulin-Resistant Patients with Polycystic Ovary Syndrome.
    Jamilian M; Foroozanfard F; Rahmani E; Talebi M; Bahmani F; Asemi Z
    Nutrients; 2017 Nov; 9(12):. PubMed ID: 29186759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The synergistic effect of sex hormone-binding globulin and aromatase genes on polycystic ovary syndrome phenotype.
    Xita N; Georgiou I; Lazaros L; Psofaki V; Kolios G; Tsatsoulis A
    Eur J Endocrinol; 2008 Jun; 158(6):861-5. PubMed ID: 18505907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of placebo-controlled insulin-sensitizing drugs on hormonal parameters in polycystic ovary syndrome patients: A network meta-analysis.
    Huang R; Zhao PF; Xu JH; Liu DD; Luo FD; Dai YH
    J Cell Biochem; 2018 Mar; 119(3):2501-2511. PubMed ID: 28941255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of n-3 polyunsaturated fatty acid on metabolic status in women with polycystic ovary syndrome: a meta-analysis of randomized controlled trials.
    Zhou J; Zuo W; Tan Y; Wang X; Zhu M; Zhang H
    J Ovarian Res; 2023 Mar; 16(1):54. PubMed ID: 36932420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metastin levels in relation with hormonal and metabolic profile in patients with polycystic ovary syndrome.
    Yilmaz SA; Kerimoglu OS; Pekin AT; Incesu F; Dogan NU; Celik C; Unlu A
    Eur J Obstet Gynecol Reprod Biol; 2014 Sep; 180():56-60. PubMed ID: 25020276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.